Novocure Appoints Frank Leonard as CEO After 15+ Years Driving Growth

Baar, Switzerland and Portsmouth, NH, December 3, 2025 (Business Wire) -- Novocure (NASDAQ: NVCR) named Frank Leonard as its new Chief Executive Officer, effective immediately, following the resignation of Ashley Cordova. Leonard, previously Novocure’s President, has spent over 15 years leading global business operations and helping launch the company’s device-based cancer therapies.

William Doyle, Executive Chairman, highlighted Leonard’s pivotal role in shaping Novocure’s culture, preparing for its first commercial launch, and driving organizational growth, calling him “the ideal person” to guide the company through upcoming transformative milestones.

Read full article here.